Making Medicine

By: Incubate Coalition
Listen for free

  • Summary

  • There's a scientific breakthrough in your medicine cabinet. But how did it get there?

    At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.

    From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.

    In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
    Copyright Sweet Fish
    Show more Show less
activate_WEBCRO358_DT_T2
Episodes
  • CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics

    CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics
    Jun 28 2024
    As part of our inaugural CEO series, we're excited to welcome Sherine Chan, the CEO and Co-Founder of Neuroene Therapeutics.

    In this episode, Sherine shares her journey from academia to helming a cutting-edge biotech company. She explores the groundbreaking work her company is pioneering in targeting the powerhouses of cells: mitochondria. Sherine also dives into the influence of the Inflation Reduction Act on the development of small-molecule drugs

    We also discuss:
    • Neuroene Therapeutics' ongoing projects.
    • The critical role of mitochondrial dysfunction in neurological conditions such as epilepsy, Parkinson's, and mitochondrial disorders.
    • Sherine's insights for aspiring entrepreneurs and scientists.
    Show more Show less
    17 mins
  • Dispelling Misconceptions in Biopharmaceutical IP Regulation

    Dispelling Misconceptions in Biopharmaceutical IP Regulation
    May 3 2024
    On World IP Day, Kirsten Axelsen, Senior Advisor of the Incubate Policy Lab, joins host John Stanford to announce the newest whitepaper, delve into the myths and realities surrounding IP in the pharmaceutical industry, explore the dynamics of patent regulations, and touch on the contentious discussions around patent thickets and pharmaceutical pricing under new legislative environments like the Inflation Reduction Act.

    Join us as we also discuss:
    • What to expect out of the Incubate Policy Lab
    • The role that venture investment plays in advancing promising science and technology.
    • The latest whitepaper that addresses misconceptions about IP
    • The implications of IRA policies in weakening the generics industry, potentially disrupting the balance that has historically led to affordable drug pricing post-patent expiration.
    Show more Show less
    25 mins
  • When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act

    When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act
    Apr 11 2024
    Joe Allen, Executive Director of The Bayh-Dole Coalition, was at the forefront of the Bayh-Dole Act back in December 1980, which allowed researchers to own inventions resulting from federally funded research. However, 43 years later, the March-In Rights framework proposed by the Biden administration threatens to weaken America’s innovation. In this episode, Joe delves into the potential implications of this framework on drug pricing, the pipeline, and overall innovation.

    Join us as we discuss:
    • The significance of the Bayh-Dole Act and intellectual property in transforming how America drives innovation.
    • Why public-private partnerships and collaboration in the medical field are key for funding research projects.
    • The implications of enacting March-In Rights on the drug development pipeline
    Show more Show less
    22 mins
Hygiene & Healthy Living
Show more Show less

What listeners say about Making Medicine

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available